We are leveraging our expertise in stem cell biology to develop innovative, disease-transforming cellular therapeutics for the treatment of patients with rare, life-threatening diseases. Our therapeutic approach utilizes established pharmacologic modalities, such as small molecules and proteins, and targets well-characterized biological mechanisms to program cell function and fate. We have particular interest in the areas of hematopoiesis and skeletal muscle biology, where the physiological role of adult stem cells has been well characterized and established through medical and/or biological precedent. We are applying our novel approach to develop first-in-kind programmed cell therapeutic candidates for the treatment of hematologic malignancies, rare genetic disorders and degenerative diseases. http://fatetherapeutics.com/therapeutic-programs/ |